Clinical Trial

IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4

Study acronym: IMPARTER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of the study is to determine if provision of a patient information film about Oncotype DX improves patients' knowledge and understanding about Gene Expression Profiling (GEP) test and risk of recurrence results in early breast cancer (EBC) patients, identified by their clinical teams as potentially benefiting from having their tumor samples sent for GEP analysis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-21.
Trial Details
NCT Number NCT06703567
Lead Sponsor European Institute of Oncology
Conditions Breast Cancer
Enrollment 82 participants
Start Date 2024-09-06
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-10